Did not become law. It stopped in the Senate on March 11, 2020. The 2020 session has ended.
2020 Regular Session
Senate Bill 251
AN ACT CONCERNING THE AVAILABILITY OF GENERIC PHARMACEUTICALS.
What it does
The synopsis the General Assembly published with the bill.
To preserve consumer access to affordable generic drugs.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
Its course
February 26 to March 11, 2020, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action4 actions on 4 days
In the SenateFeb 26 to Mar 11 · stopped14 days
General Law CommitteeFeb 26 to Mar 1013 days
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.
In the Senate Feb 26 – Mar 10
- Feb 26Introduced and sent to General Law Committee
- Feb 27Heard in General Law Committee
- Mar 10General Law Committee recommended it
All 4 actions, as published
- Feb 26REF. TO JOINT COMM. ONBoth houses
- Feb 27PUBLIC HEARINGBoth houses
- Mar 10Joint FavorableBoth houses
- Mar 11FILED WITH LCOBoth houses